INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $52,625 | +31.6% | 250,000 | 0.0% | 0.01% | +22.2% |
| Q1 2023 | $40,000 | -71.2% | 250,000 | 0.0% | 0.01% | -70.0% |
| Q4 2022 | $138,750 | -53.4% | 250,000 | 0.0% | 0.03% | -51.6% |
| Q3 2022 | $298,000 | +88.6% | 250,000 | 0.0% | 0.06% | +87.9% |
| Q2 2022 | $158,000 | -44.6% | 250,000 | 0.0% | 0.03% | -35.3% |
| Q1 2022 | $285,000 | -49.4% | 250,000 | 0.0% | 0.05% | -42.0% |
| Q4 2021 | $563,000 | -34.2% | 250,000 | 0.0% | 0.09% | -36.7% |
| Q3 2021 | $855,000 | +14.3% | 250,000 | 0.0% | 0.14% | +23.0% |
| Q2 2021 | $748,000 | -53.7% | 250,000 | -50.0% | 0.11% | -18.1% |
| Q1 2021 | $1,616,000 | +204.9% | 500,000 | +100.0% | 0.14% | +34.0% |
| Q4 2020 | $530,000 | +81.5% | 250,000 | 0.0% | 0.10% | +98.1% |
| Q3 2020 | $292,000 | +29.2% | 250,000 | 0.0% | 0.05% | +30.0% |
| Q2 2020 | $226,000 | -46.1% | 250,000 | -50.0% | 0.04% | -63.6% |
| Q1 2020 | $419,000 | -12.7% | 500,000 | 0.0% | 0.11% | +44.7% |
| Q4 2019 | $480,000 | – | 500,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |